Stay updated on EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial
Sign up to get notified when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.

Latest updates to the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor release update to the page's version metadata rather than a content change.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page shows a new revision number (v3.6.4) replacing the previous one, indicating a lightweight platform update rather than a substantive change to the study details.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3 on the page, indicating a minor maintenance update to the page's metadata. No study content or results are affected.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page now shows revision v3.6.2 in place of v3.6.0, indicating a routine site update. The change does not modify study details or interactions on the page.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page now shows that recruitment has ended, and additional navigation/help sections were added or updated to improve access to study information.SummaryDifference0.6%

- Check83 days agoChange DetectedThe page now shows Revision: v3.5.5, indicating a frontend update. No study data or content has changed.SummaryDifference0.0%

Stay in the know with updates to EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.